FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Healix Infusion Therapy fentaNYL 5000 mcg/250 mL Recall

fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0

Healix Infusion Therapy, Inc. · Sugar Land, TX

Risk level
Class II
Reported by FDA
Aug 27, 2014
Recall ID
D-1555-2014
Check your lot numberHow we source this data

Summary

Healix Infusion Therapy recalled fentaNYL 5000 mcg/250 mL starting Jun 27, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1555-2014 on Aug 27, 2014. Reason: Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Product description

fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0.9% Sodium Chloride in a flexable bag, COMPOUNDED DRUG For Institutional or Office Use Only--Not for Resale, Federal Law Prohibits Dispensing without Prescription Healix Infusion Therapy, Inc. (866) 298-4826 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478, NDC 75901-8015-04

Lot numbers, UPCs & expiration codes

Lot 7257-0 Exp. 08/14

Where it was sold

Texas and Georgia

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1555-2014
Classification
Class II
Status
Terminated
Recall initiated
Jun 27, 2014
FDA report date
Aug 27, 2014
Recall type
Voluntary: Firm initiated
Recalling firm
Healix Infusion Therapy, Inc.

Original FDA data

Every field from FDA enforcement report D-1555-2014, exactly as published.

Show all FDA fields
City
Sugar Land
State
TX
Status
Terminated
Country
United States
Event ID
69056
Address
1075 W Park One Dr Suite 200
Code information
Lot 7257-0 Exp. 08/14
Postal code
77478-2576
Report date
Aug 27, 2014
Product type
Drugs
Recall number
D-1555-2014
Classification
Class II
Recalling firm
Healix Infusion Therapy, Inc.
Termination date
Aug 25, 2015
Reason for recall
Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0.9% Sodium Chloride in a flexable bag, COMPOUNDED DRUG For Institutional or Office Use Only--Not for Resale, Federal Law Prohibits Dispensing without Prescription Healix Infusion Therapy, Inc. (866) 298-4826 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478, NDC 75901-8015-04
Distribution pattern
Texas and Georgia
Recall initiation date
Jun 27, 2014
Initial firm notification
Letter
Center classification date
Aug 21, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1555-2014, published Aug 27, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls